Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
This is the single biggest point of failure in the entire research supply chain
IQVIA EMEA Thought Leadership analysis Label expansion into co-morbidities: On 20 March 2024, Wegovy became the first obesity therapy with an expanded label as the FDA approved inclusion of the reduction in the risk of cardiovascular death, heart attack and stroke, following the successful SELECT CV outcomes trial in 2023
Your GP will determine the most suitable route based on your individual circumstances
Clean the rubber stopper with an alcohol swab and allow it to dry
US$ 26.22
US$ 26.72
US$ 21.09
US$ 20.96
US$ 24.29
US$ 28.65
US$ 26.21
US$ 26.16
